BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

Statins shown to induce bone growth in stem cell models of dwarfism

Sep. 24, 2014
By John Fox
HONG KONG - Treatment with cholesterol-lowering statins has been shown to induce partial recovery of bone growth in mouse models of dwarfism, suggesting those agents could be useful for the medical treatment of infants and children with growth disorders such as achondroplasia and thanatophoric dysplasia.
Read More

Statins shown to induce bone growth in stem cell models of dwarfism

Sep. 23, 2014
By John Fox
HONG KONG - Treatment with cholesterol-lowering statins has been shown to induce partial recovery of bone growth in mouse models of dwarfism, suggesting those agents could be useful for the medical treatment of infants and children with growth disorders such as achondroplasia and thanatophoric dysplasia.
Read More

Small molecule a promising lead candidate for new HCC therapy

Sep. 19, 2014
By John Fox
HONG KONG - Researchers from the Chinese University of Hong Kong (CUHK) have identified a small-molecule compound that dramatically inhibited tumor growth in a mouse model of hepatocellular carcinoma (HCC), representing a promising lead candidate for further investigation as an urgently needed new class of HCC therapy.
Read More

First evidence for genetic diversity influencing influenza virulence

Sep. 10, 2014
By John Fox
HONG KONG – A study by British and University of Hong Kong (HKU) researchers has provided the first direct evidence that reduced genetic diversity is associated with a reduction in virulence of the influenza A virus (IAV) in mice, providing a target for development of new antiviral drugs and a means to improve live attenuated vaccines.
Read More

First evidence for genetic diversity influencing influenza virulence

Sep. 9, 2014
By John Fox
HONG KONG – A study by British and University of Hong Kong (HKU) researchers has provided the first direct evidence that reduced genetic diversity is associated with a reduction in virulence of the influenza A virus (IAV) in mice, providing a target for development of new antiviral drugs and a means to improve live attenuated vaccines.
Read More

Important clue found to origins, potential new treatments for epileps

Aug. 29, 2014
By John Fox
HONG KONG – A team of Korean researchers has used gene knockout techniques in mice to gain an improved understanding of the role played by the thalamic reticular nucleus (TRN) in absence seizures, which may lead to the development of effective new treatment methods for that form of epilepsy.
Read More

Important clue found to origins and potential new treatments for absence epilepsy

Aug. 27, 2014
By John Fox
HONG KONG – A team of Korean researchers has used gene knockout techniques in mice to gain an improved understanding of the role played by the thalamic reticular nucleus (TRN) in absence seizures, which may lead to the development of effective new treatment methods for that form of epilepsy.
Read More

VLP vaccine promising against chikungunya

Aug. 20, 2014
By John Fox
HONG KONG – The first human trial of a new vaccine based on virus-like particles (VLPs) suggests it is safe and effective against the rapidly emerging mosquito-borne chikungunya virus, researchers reported in the Aug. 15 early online edition of The Lancet.
Read More

VLP vaccine promising against chikungunya

Aug. 20, 2014
By John Fox
HONG KONG – The first human trial of a new vaccine based on virus-like particles (VLPs) suggests it is safe and effective against the rapidly emerging mosquito-borne chikungunya virus, researchers reported in the Aug. 15, 2014, early online edition of The Lancet.
Read More

Researchers resolve bone growth debate

Aug. 13, 2014
By John Fox
HONG KONG – Researchers here have shown for the first time that during bone formation and growth, cartilage cells or chondrocytes survive and develop into mature osteoblasts, the cells that form new bone, contradicting the long-held tenet that chondrocytes and osteoblasts are separate independently developing cell types.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing